Clinical Research Coordinator at NNI-SG

National Neuroscience Institute, Singapore

Neurocognitive Research & Clinical Centre (NRCC), Department of Neurology

Lab head: Prof. Nagaendran Kandiah

Roles: Clinical Research Coordinator (2017 - 2018), Senior Research Assistant (2013 - 2017)

IMG_1238.JPG

Career Highlights

  • Involved in study design and coordination of investigator-initiated trials, and in administration of study procedures in pharmaceutical clinical trials

  • Various research projects on dementia, healthy aging, Parkinson's disease, stroke, and autoimmune encephalitis

  • Neuropsychological assessment

  • Neuroimaging qualitative and volumetric analysis

  • Mid-level statistical analysis in Stata and SPSS

  • Assisting in drafting of abstracts and manuscripts for publication, and presentations in international conferences

  • Some wet lab experience (biological sample preparation, genomic DNA extraction)

  • Some volunteer involvement in dementia and brain health public awareness campaigns, and dementia caregiver support

Screenshot_20200902-120814.jpg

Conferences Attended

  • 3rd Singapore International Neurocognitive Symposium – 5-6 April 2013; Singapore

  • National Neuroscience Institute Research Day – 19 July 2013; Singapore

  • 2014 Alzheimer’s Association International Conference – 12-17 July 2014; Copenhagen, Denmark

  • 2014 SingHealth Duke-NUS Scientific Congress 2014 – 5-6 September 2014; Singapore

  • SingHealth Duke-NUS Neuroscience ACP Research Day – 6 February 2015; Singapore

  • 4th Singapore International Neurocognitive Symposium – 27-28 May 2015; Singapore

  • 2015 Alzheimer’s Association International Conference – 18-23 July 2015; Washington D.C., USA

  • SingHealth Duke-NUS Scientific Congress 2016 – 23-24 September 2016; Singapore

  • 5th Singapore International Neurocognitive Symposium – 16-18 March 2017; Singapore

  • 2017 Alzheimer’s Association International Conference – 16-20 July 2017; London, UK

IMG_9004.jpg

My publications

While at NNI, I was involved in numerous publications on cognitive impairment, Alzheimer’s disease and other dementias, Parkinson’s disease, ischemic stroke, and other neurological conditions.

IMG_1124.jpg

Research Projects

Investigator-initiated studies

The influence of small vessel cerebrovascular lesions on cognition and tau in Parkinson’s disease [National Neuroscience Institute, Singapore; 2013 – 2014]

  • Main protocol administrator

  • Data collection and analysis – cognitive and neuroimaging

The frequency of anti-NMDA receptor and anti-VGKC encephalitides in patients presenting with first-episode psychosis [National Neuroscience Institute, Singapore; 2013 – 2014] - Main protocol administrator

  • Data collection – cognitive

Multimodal connectome analysis for differentiating subtypes within early-stage dementia and mild cognitive impairment [National Neuroscience Institute, Singapore; 2013 – 2016]

  • Main protocol administrator

  • Data collection and analysis – cognitive and neuroimaging

PAWS - Parkinson's and Alzheimer's disease and impact of White matter disease Study [National Neuroscience Institute, Singapore; 2014 – present] - Data collection and analysis – cognitive and neuroimaging (2014 – 2018)

  • Collaborator (2018 – present)

Correlation of cognition profile and cerebral ischemia among stroke patients attending National Neuroscience Institute outpatient clinics – The Singapore Ischemic Stroke Cognitive Outcomes (SISCO) study [National Neuroscience Institute, Singapore; 2013 – present]

  • Main protocol administrator (2013 – 2018)

  • Data collection and analysis – neuroimaging visual rating (2013 – 2018)

  • Collaborator (2018 – present)

Study to elucidate the influence of neuroinflammation including “Damage Associated Molecular Patterns (DAMPs)” in the sundrome of Alzheimer’s disease with small vessel cerebrovascular disease (AD+svCVD) [National Neuroscience Institute, Singapore; 2014 – 2018]

  • Data collection – cognitive

Singapore YouNg dementia Cohort (SYNC) study: Clinical, pathophysiological, and economic cost characterization [National Neuroscience Institute, Singapore; 2015 – present]

  • Data collection and analysis – cognitive and neuroimaging (2015 – 2018)

  • Neuropsychological reports and case presentations (2015 – 2018)

  • Collaborator (2018 – present)

Subjective cognitive decline and objective cognitive deficits in Singaporean community elderly [National Neuroscience Institute, Singapore; 2015 – present]

  • Main protocol administrator (2015 – 2018)

  • Data collection - cognitive (2018 – present)

STROKOG international consortium of longitudinal studies of cognitive disorders following stroke [University of New South Wales; 2016 – present]

  • Study site coordinator (National Neuroscience Institute, Singapore; 2016 – 2018)

  • Collaborator (2018 – present)

Clinical effects and pathophysiology of vitamin deficiency in neurocognitive disorders: The Vitamins, brain Imaging, and Cognition - Singapore Study (VICSS) [National Neuroscience Institute, Singapore; 2017 – present]

  • Main protocol administrator (2017 – 2018)

  • Collaborator (2018 – present)

Clinical trials

Double-blind, placebo-controlled, randomized, parallel-group, 12-month safety and efficacy trial of leuco-methylthioninium bis(hydromethanesulfonate) in subjects with behavioral variant frontotemporal dementia (bvFTD) [TauRx Therapeutics]

  • Unblinded rater

Randomized, double-bling, placebo controlled, parallel-group, 12-month trial of leuco-methylthioninium bis(hydromethanesulfonate) in subjects with mild to moderate Alzheimer's disease study: Phase 3 [TauRx Therapeutics]

  • Unblinded rater

An open-label extension study of the effects of leuco-methylthioninium bis(hydromethanesulfonate) in subjects with Alzheimer's disease or behavioural variant frontotemporal dementia [TauRx Therapeutics]

  • Unblinded rater

Randomized, double-blind, parallel-group, placebo-controlled study of Lu AE58054 in patients with mild-moderate Alzheimers disease treated with an acetylcholinesterase inhibitor; Study 3 [Lundbeck]

  • Unblinded rater

Open-label trial of rivastigmine patch in subjects with mild to moderate stage Alzheimer's disease having coexisting small-vessel cerebrovascular disease [Novartis]

  • Unblinded rater